Laparoscopic Gynecological Procedures Market Size, Share & Trends Analysis Report By Procedure (Laparoscopic Hysterectomy, Laparoscopic Myomectomy), By End Use (Clinics, ASCs, Hospitals), By Region, And Segment Forecasts, 2025 to 2030
Description
Laparoscopic Gynecological Procedures Market Summary
The global laparoscopic gynecological procedures market size was estimated at USD 19.9 billion in 2024 and is projected to reach USD 24.0 billion by 2030, growing at a CAGR of 3.2% from 2025 to 2030. Laparoscopic gynecological procedures are experiencing growth due to the increasing adoption of minimally invasive surgeries, driven by patient preference for reduced recovery times and less scarring, the rising prevalence of gynecological disorders, such as uterine fibroids and endometriosis, and technological advancements, including robotic-assisted surgery.
The growing preference for minimally invasive surgeries (MIS) is a primary driver for the rising adoption of laparoscopic gynecological procedures, particularly in the treatment of conditions such as endometriosis, fibroids, ovarian cysts, and ectopic pregnancies. Laparoscopic gynecology offers shorter recovery times, reduced hospital stays, lower post-operative complications, and minimal scarring, which align with patient-centric trends in modern healthcare. Similarly, for healthcare providers, the increased efficiency in operating room (OR) turnover and reduced postoperative care demand are driving procedural volumes in ambulatory surgical centers (ASCs) and outpatient gynecology clinics, which is increasing their preference towards laparoscopic procedures.
Global Laparoscopic Gynecological Procedures Market Report Segmentaton
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global laparoscopic gynecological procedures market based on procedure, end use, and region:
The global laparoscopic gynecological procedures market size was estimated at USD 19.9 billion in 2024 and is projected to reach USD 24.0 billion by 2030, growing at a CAGR of 3.2% from 2025 to 2030. Laparoscopic gynecological procedures are experiencing growth due to the increasing adoption of minimally invasive surgeries, driven by patient preference for reduced recovery times and less scarring, the rising prevalence of gynecological disorders, such as uterine fibroids and endometriosis, and technological advancements, including robotic-assisted surgery.
The growing preference for minimally invasive surgeries (MIS) is a primary driver for the rising adoption of laparoscopic gynecological procedures, particularly in the treatment of conditions such as endometriosis, fibroids, ovarian cysts, and ectopic pregnancies. Laparoscopic gynecology offers shorter recovery times, reduced hospital stays, lower post-operative complications, and minimal scarring, which align with patient-centric trends in modern healthcare. Similarly, for healthcare providers, the increased efficiency in operating room (OR) turnover and reduced postoperative care demand are driving procedural volumes in ambulatory surgical centers (ASCs) and outpatient gynecology clinics, which is increasing their preference towards laparoscopic procedures.
Global Laparoscopic Gynecological Procedures Market Report Segmentaton
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global laparoscopic gynecological procedures market based on procedure, end use, and region:
- Procedure Outlook (Revenue, USD Million, 2018 - 2030)
- Laparoscopic Hysterectomy
- Laparoscopic Adnexal
- Laparoscopic Endometrial Excision
- Laparoscopic Diagnostic Procedures
- Laparoscopic Myomectomy
- Laparoscopic Colpopexy
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory Surgery Centers
- Clinics
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
120 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Procedure
- 1.2.2. End Use
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Procedure outlook
- 2.2.2. End use outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
- Chapter 3. Laparoscopic Gynecological Procedures Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Laparoscopic Gynecological Procedures Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- Chapter 4. Laparoscopic Gynecological Procedures Market: Procedure Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Laparoscopic Gynecological Procedures Procedure Market Movement Analysis
- 4.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
- 4.4. Laparoscopic Hysterectomy
- 4.4.1. Laparoscopic Hysterectomy market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Laparoscopic Adnexal
- 4.5.1. Laparoscopic Adnexal market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Laparoscopic Endometrial Excision
- 4.6.1. Laparoscopic Endometrial Excision market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Laparoscopic Diagnostic Procedures
- 4.7.1. Laparoscopic Diagnostic Procedures market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8. Laparoscopic Myomectomy
- 4.8.1. Laparoscopic Myomectomy market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9. Laparoscopic Colpopexy
- 4.9.1. Laparoscopic Colpopexy market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 5. Laparoscopic Gynecological Procedures Market: End Use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Laparoscopic Gynecological Procedures End Use Market Movement Analysis
- 5.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 5.4. Hospitals
- 5.4.1. Hospitals’ market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Clinics
- 5.5.1. Clinics market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Ambulatory Surgery Centers
- 5.6.1. Ambulatory Surgery Centers market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 6. Laparoscopic Gynecological Procedures Market: Regional Estimates & Trend Analysis By Procedure, End Use
- 6.1. Regional Market Share Analysis, 2025 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Global Regional Market Snapshot
- 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
- 6.5. North America
- 6.5.1. U.S.
- 6.5.1.1. Key country dynamics
- 6.5.1.2. Competitive scenario
- 6.5.1.3. Regulatory framework
- 6.5.1.4. Reimbursement structure
- 6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.2. Canada
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Competitive scenario
- 6.5.2.3. Regulatory framework
- 6.5.2.4. Reimbursement structure
- 6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.3. Mexico
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Competitive scenario
- 6.5.3.3. Regulatory framework
- 6.5.3.4. Reimbursement structure
- 6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Europe
- 6.6.1. UK
- 6.6.1.1. Key country dynamics
- 6.6.1.2. Competitive scenario
- 6.6.1.3. Regulatory framework
- 6.6.1.4. Reimbursement structure
- 6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.2. Germany
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Competitive scenario
- 6.6.2.3. Regulatory framework
- 6.6.2.4. Reimbursement structure
- 6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.3. France
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Competitive scenario
- 6.6.3.3. Regulatory framework
- 6.6.3.4. Reimbursement structure
- 6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.4. Italy
- 6.6.4.1. Key country dynamics
- 6.6.4.2. Competitive scenario
- 6.6.4.3. Regulatory framework
- 6.6.4.4. Reimbursement structure
- 6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.5. Spain
- 6.6.5.1. Key country dynamics
- 6.6.5.2. Competitive scenario
- 6.6.5.3. Regulatory framework
- 6.6.5.4. Reimbursement structure
- 6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.6. Norway
- 6.6.6.1. Key country dynamics
- 6.6.6.2. Competitive scenario
- 6.6.6.3. Regulatory framework
- 6.6.6.4. Reimbursement structure
- 6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.7. Sweden
- 6.6.7.1. Key country dynamics
- 6.6.7.2. Competitive scenario
- 6.6.7.3. Regulatory framework
- 6.6.7.4. Reimbursement structure
- 6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.8. Denmark
- 6.6.8.1. Key country dynamics
- 6.6.8.2. Competitive scenario
- 6.6.8.3. Regulatory framework
- 6.6.8.4. Reimbursement structure
- 6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Asia Pacific
- 6.7.1. Japan
- 6.7.1.1. Key country dynamics
- 6.7.1.2. Competitive scenario
- 6.7.1.3. Regulatory framework
- 6.7.1.4. Reimbursement structure
- 6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.2. China
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Competitive scenario
- 6.7.2.3. Regulatory framework
- 6.7.2.4. Reimbursement structure
- 6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.3. India
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Competitive scenario
- 6.7.3.3. Regulatory framework
- 6.7.3.4. Reimbursement structure
- 6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.4. Australia
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Competitive scenario
- 6.7.4.3. Regulatory framework
- 6.7.4.4. Reimbursement structure
- 6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.5. South Korea
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Competitive scenario
- 6.7.5.3. Regulatory framework
- 6.7.5.4. Reimbursement structure
- 6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.6. Thailand
- 6.7.6.1. Key country dynamics
- 6.7.6.2. Competitive scenario
- 6.7.6.3. Regulatory framework
- 6.7.6.4. Reimbursement structure
- 6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8. Latin America
- 6.8.1. Brazil
- 6.8.1.1. Key country dynamics
- 6.8.1.2. Competitive scenario
- 6.8.1.3. Regulatory framework
- 6.8.1.4. Reimbursement structure
- 6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8.2. Argentina
- 6.8.2.1. Key country dynamics
- 6.8.2.2. Competitive scenario
- 6.8.2.3. Regulatory framework
- 6.8.2.4. Reimbursement structure
- 6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9. MEA
- 6.9.1. South Africa
- 6.9.1.1. Key country dynamics
- 6.9.1.2. Competitive scenario
- 6.9.1.3. Regulatory framework
- 6.9.1.4. Reimbursement structure
- 6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.2. Saudi Arabia
- 6.9.2.1. Key country dynamics
- 6.9.2.2. Competitive scenario
- 6.9.2.3. Regulatory framework
- 6.9.2.4. Reimbursement structure
- 6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.3. UAE
- 6.9.3.1. Key country dynamics
- 6.9.3.2. Competitive scenario
- 6.9.3.3. Regulatory framework
- 6.9.3.4. Reimbursement structure
- 6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.4. Kuwait
- 6.9.4.1. Key country dynamics
- 6.9.4.2. Competitive scenario
- 6.9.4.3. Regulatory framework
- 6.9.4.4. Reimbursement structure
- 6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Key company market share analysis, 2025
- 7.4. Company Position Analysis
- 7.5. Company Categorization (Emerging Players, Innovators and Leaders)
- 7.6. Company Profiles
- 7.6.1. Medtronic
- 7.6.1.1. Company overview
- 7.6.1.2. Financial performance
- 7.6.1.3. Product benchmarking
- 7.6.1.4. Strategic initiatives
- 7.6.2. Stryker
- 7.6.2.1. Company overview
- 7.6.2.2. Financial performance
- 7.6.2.3. Product benchmarking
- 7.6.2.4. Strategic initiatives
- 7.6.3. Karl Storz SE & CO. Kg
- 7.6.3.1. Company overview
- 7.6.3.2. Financial performance
- 7.6.3.3. Product benchmarking
- 7.6.3.4. Strategic initiatives
- 7.6.4. Johnson and Johnson
- 7.6.4.1. Company overview
- 7.6.4.2. Financial performance
- 7.6.4.3. Product benchmarking
- 7.6.4.4. Strategic initiatives
- 7.6.5. Olympus Corporation
- 7.6.5.1. Company overview
- 7.6.5.2. Financial performance
- 7.6.5.3. Product benchmarking
- 7.6.5.4. Strategic initiatives
- 7.6.6. CONMED Corporation
- 7.6.6.1. Company overview
- 7.6.6.2. Financial performance
- 7.6.6.3. Product benchmarking
- 7.6.6.4. Strategic initiatives
- 7.6.7. B. Braun SE
- 7.6.7.1. Company overview
- 7.6.7.2. Financial performance
- 7.6.7.3. Product benchmarking
- 7.6.7.4. Strategic initiatives
- 7.6.8. CooperCompanies
- 7.6.8.1. Company overview
- 7.6.8.2. Financial performance
- 7.6.8.3. Product benchmarking
- 7.6.8.4. Strategic initiatives
- 7.6.9. Richard Wolf GmbH
- 7.6.9.1. Company overview
- 7.6.9.2. Financial performance
- 7.6.9.3. Product benchmarking
- 7.6.9.4. Strategic initiatives
- 7.6.10. Microline Surgical
- 7.6.10.1. Company overview
- 7.6.10.2. Financial performance
- 7.6.10.3. Product benchmarking
- 7.6.10.4. Strategic initiatives
- 7.6.11. Welfare Medical Ltd.
- 7.6.11.1. Company overview
- 7.6.11.2. Financial performance
- 7.6.11.3. Product benchmarking
- 7.6.11.4. Strategic initiatives
- 7.6.12. Intuitive Surgical
- 7.6.12.1. Company overview
- 7.6.12.2. Financial performance
- 7.6.12.3. Product benchmarking
- 7.6.12.4. Strategic initiatives
- 7.6.13. Shenzhen Mindray Bio Medical Electronics Co., Ltd.
- 7.6.13.1. Company overview
- 7.6.13.2. Financial performance
- 7.6.13.3. Product benchmarking
- 7.6.13.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


